戻る Agenda
Session 2: How RBM Binds all Stakeholders - Data Managers, Statisticians, Monitors, Investigators and Inspectors
Session Chair(s)
Mette Mackeprang Bruhn, MA
Team Leader, Novo Nordisk A/S, Denmark
How RBM Binds all Stakeholders - Data Managers, Statisticians, Monitors, Investigators and Inspectors
Speaker(s)
The Evolving Role of the Clinical Data Manager in the Times of Risk-based Monitoring
Johann Proeve, PhD
Chief Scientific Officer, Cyntegrity, Germany
Risk-Based Monitoring – Perspective from a Statistician
Nicola Schmitt
Global Product Statistician, AstraZeneca, United Kingdom
Big Data' Analytic Methods to Simplify Risk-Based-Monitoring and Fraud Detection in Clinical Trials
Hartmut Schmied
Vice President, Head of European Operations , Biorasi, Germany
Using Powerful and Pragmatic Central Statistical analytics to Drive Quality into Clinical Trials
Erik Doffagne, MS
Product Manager, CluePoints, Belgium